Prices of medicines can be adjusted up to 5.83%
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Prices of drugs may suffer a further increase from March 31. This is because the annual adjustment of prices of medicines was approved as resolution of the Board of Market Regulation of Medicines (CMED), published in the last 25 days in the Diário Oficial da União
The resolution determines the CMED edit a specific resolution on how to define the Manufacturer Price and Maximum Price Consumer Index as the National Consumer Price Large (IPCA).
In this case, the adjustments can significantly impact the consumer's pocket, since the estimate of the Inter Department of Statistics and Socioeconomic Studies (Dieese) is that the index varies from 0.48% in February. If this prediction is confirmed, the IPCA should close the period of 12 months ranging from 5.83%.
According to the Instituto Paranaense de Desenvolvimento Econômico e Social (Ipardes), the costs of drugs represent a share of 3.51% in the pocket of the consumer. However the Council of Pharmacy Refional of Paraná (CRF-PR), the average increase up to this index.
The president of the Regional Council of Pharmacy of Paraná, Roberto Diniz aulo, it expected an average increase of 6%. "The consumer will feel a little, especially those consumer that makes use of continuous medication, he can not stop buying," he says.
Furthermore, Diniz believe that another resolution issued by the National Sanitary Surveillance Agency (Anvisa), which he says should go into effect in June, should contribute to reducing the prices of medicines. According to Diniz, the intention is to prohibit the advertising of medicines.
Diniz also warns of another factor that may swing the price of medicines. He explains that in June there may be a replacement tax that should require establishments to bear an even greater contribution of the load of ICMS, now divided among laboratories.
According to him, this may cause the discount that is offered in each product is limited to 8%. For the pharmacy manager of Minerva, Bruno Mesquita, an exit is to continue investing in the sale of items of perfumery.
He says the intention is that the items of perfumery is 40% of pharmacy sales of the medicines that can relieve the responsibility for vialibidade the business.
Mosque is still not optimistic about the possibility of adjustment. "Certainly there will be an impact both for the consumer as to our sales volume," he says. "We are facing a general crisis. Therefore we must be careful not to further unbalance the economy of the sectors, "he says.
Source: Paraná Online
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.
